BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 23995112)

  • 1. Portal vein thrombosis during eltrombopag treatment for immune thrombocytopenic purpura in a patient with liver cirrhosis due to hepatitis C viral infection.
    Kawano N; Hasuike S; Iwakiri H; Nakamura K; Ozono Y; Kusumoto H; Nagata K; Kikuchi I; Yoshida S; Kuriyama T; Yamashita K; Muranaka T; Kawaguchi T; Sata M; Okamura T; Ueda A; Shimoda K
    J Clin Exp Hematop; 2013; 53(2):151-5. PubMed ID: 23995112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Portal vein thrombosis as complication of romiplostim treatment in a cirrhotic patient with hepatitis C-associated immune thrombocytopenic purpura.
    Dultz G; Kronenberger B; Azizi A; Mihm U; Vogl TJ; Sarrazin U; Sarrazin C; Zeuzem S; Hofmann WP
    J Hepatol; 2011 Jul; 55(1):229-32. PubMed ID: 21310200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eltrombopag increases platelet numbers in thrombocytopenic patients with HCV infection and cirrhosis, allowing for effective antiviral therapy.
    Afdhal NH; Dusheiko GM; Giannini EG; Chen PJ; Han KH; Mohsin A; Rodriguez-Torres M; Rugina S; Bakulin I; Lawitz E; Shiffman ML; Tayyab GU; Poordad F; Kamel YM; Brainsky A; Geib J; Vasey SY; Patwardhan R; Campbell FM; Theodore D
    Gastroenterology; 2014 Feb; 146(2):442-52.e1. PubMed ID: 24126097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Portal vein thrombosis.
    Olson MM; Ilada PB; Apelgren KN
    Surg Endosc; 2003 Aug; 17(8):1322. PubMed ID: 12799896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-molecular-weight heparin treatment for portal vein thrombosis in liver cirrhosis: Efficacy and the risk of hemorrhagic complications.
    Kwon J; Koh Y; Yu SJ; Yoon JH
    Thromb Res; 2018 Mar; 163():71-76. PubMed ID: 29407630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Portal and superior mesenteric vein thrombosis after splenectomy for idiopathic thrombocytopenic purpura].
    Silberstein E; Smolikov A; Levi I
    Harefuah; 1999 Mar; 136(5):364-6, 418. PubMed ID: 10914240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Thrombopoietin receptor agonists administration for acute exacerbation of chronic idiopathic thrombocytopenic purpura and subsequent anticoagulant therapy for accompanying deep venous thrombosis of the lower limbs].
    Kawano H; Suzuki T; Ishii S; Wakahashi K; Kawano Y; Sada A; Minagawa K; Takaya T; Yamashita T; Hirata K; Koriyama K; Nagamatsu Y; Matsui T; Katayama Y
    Rinsho Ketsueki; 2014 Jun; 55(6):697-702. PubMed ID: 24975340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of anticoagulation on patients with cirrhosis and portal vein thrombosis.
    Delgado MG; Seijo S; Yepes I; Achécar L; Catalina MV; García-Criado A; Abraldes JG; de la Peña J; Bañares R; Albillos A; Bosch J; García-Pagán JC
    Clin Gastroenterol Hepatol; 2012 Jul; 10(7):776-83. PubMed ID: 22289875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe Portal Vein Thrombosis During Eltrombopag Treatment Concomitant Splenectomy for Immune Thrombocytopenia.
    Saito M; Morioka M; Izumiyama K; Mori A; Kondo T
    Cureus; 2021 Aug; 13(8):e17478. PubMed ID: 34589366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombopoietin receptor agonists for preparing adult patients with immune thrombocytopenia to splenectomy: results of a retrospective, observational GIMEMA study.
    Zaja F; Barcellini W; Cantoni S; Carpenedo M; Caparrotti G; Carrai V; Di Renzo N; Santoro C; Di Nicola M; Veneri D; Simonetti F; Liberati AM; Ferla V; Paoloni F; Crea E; Volpetti S; Tuniz E; Fanin R
    Am J Hematol; 2016 May; 91(5):E293-5. PubMed ID: 26910388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Successful use of danaparoid in the treatment of portal vein thrombosis that developed in a warfarin-administered hepatitis C virus-related cirrhosis patient].
    Nawata Y; Hamada K; Tajima H; Nishino N; Nakazawa T; Tobayashi K; Saitoh S
    Nihon Shokakibyo Gakkai Zasshi; 2012 Aug; 109(8):1394-400. PubMed ID: 22863964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet Activation Assessed by Glycoprotein VI/Platelet Ratio Is Associated With Portal Vein Thrombosis After Hepatectomy and Splenectomy in Patients With Liver Cirrhosis.
    Matsui T; Usui M; Wada H; Iizawa Y; Kato H; Tanemura A; Murata Y; Kuriyama N; Kishiwada M; Mizuno S; Sakurai H; Isaji S
    Clin Appl Thromb Hemost; 2018 Mar; 24(2):254-262. PubMed ID: 29050501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticoagulation improves survival in patients with cirrhosis and portal vein thrombosis: The IMPORTAL competing-risk meta-analysis.
    Guerrero A; Campo LD; Piscaglia F; Scheiner B; Han G; Violi F; Ferreira CN; Téllez L; Reiberger T; Basili S; Zamora J; Albillos A;
    J Hepatol; 2023 Jul; 79(1):69-78. PubMed ID: 36858157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Portal vein thrombosis in hepatitis C virus-related cirrhotic patients: Prevalence and clinical characteristics in an Egyptian cohort.
    Alhaddad O; Elsabaawy M; Elshaaraawy O; Elhalawany M; Houseni MM; Abdelsameea E
    Trop Doct; 2021 Jul; 51(3):314-318. PubMed ID: 33663297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Fondaparinux and Low-Molecular-Weight Heparin in the Treatment of Portal Vein Thrombosis in Cirrhosis.
    Senzolo M; Piano S; Shalaby S; Tonon M; Tonello S; Zanetto A; Sacerdoti D; Simioni P; Bombonato G; Burra P; Angeli P
    Am J Med; 2021 Oct; 134(10):1278-1285.e2. PubMed ID: 34197784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refractory ascites due to portal vein thrombosis in liver cirrhosis--report of two cases.
    Tanaka H; Horie Y; Idobe Y; Murawaki Y; Suou T; Kawasaki H
    Hepatogastroenterology; 1998; 45(23):1777-80. PubMed ID: 9840147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Portal vein thrombosis after partial splenic embolization in liver cirrhosis: efficacy of anticoagulation and long-term follow-up.
    Cai M; Zhu K; Huang W; Meng X; He K; Zhou B; Guo Y; Chen J; Shan H
    J Vasc Interv Radiol; 2013 Dec; 24(12):1808-16. PubMed ID: 24099787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dural Venous Sinus Thrombosis and Pulmonary Embolism Following Immunoglobulin Treatment in Pediatric Patient With Immune Thrombocytopenic Purpura.
    Park KM; Yang EJ; Lim YT
    J Pediatr Hematol Oncol; 2017 Nov; 39(8):e508-e511. PubMed ID: 29068869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AGA Clinical Practice Update: Coagulation in Cirrhosis.
    O'Leary JG; Greenberg CS; Patton HM; Caldwell SH
    Gastroenterology; 2019 Jul; 157(1):34-43.e1. PubMed ID: 30986390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Portal vein thrombosis in liver cirrhosis: incidence, management, and outcome.
    Fujiyama S; Saitoh S; Kawamura Y; Sezaki H; Hosaka T; Akuta N; Kobayashi M; Suzuki Y; Suzuki F; Arase Y; Ikeda K; Kumada H
    BMC Gastroenterol; 2017 Oct; 17(1):112. PubMed ID: 29070023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.